MedTrace Logo

Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology

NCT07781397 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-08-24

No results posted yet for this study

Summary

This study evaluates whether a drug-free, non-invasive haptic patch (LIBERTY Patch) affects fall-risk classification and balance/mobility confidence in adults ages 55 to 85. Approximately 150 participants are assigned to wear either the active LIBERTY Patch or a visually identical sham patch daily for 7 days. Balance and mobility are assessed using the FallSkip wearable device and a Falls Efficacy Scale questionnaire at baseline and again after 7 days. Neither participants nor investigators know which patch is assigned during the study period, though this can be unblinded in an emergency.

Conditions

  • Fall Risk
  • Fall Risk, Fall Prevention
  • Accidental Falls
  • Accidental Falls/Prevention & Control

Interventions

DEVICE

LIBERTY Patch

A drug-free, non-invasive, investigational topical patch designed to assist with balance and mobility, worn daily for 7 days.

DEVICE

Sham Patch

A visually identical patch without active technology, worn daily for 7 days under the same conditions as the active patch.

Sponsors & Collaborators

  • Clarity Science LLC

    collaborator INDUSTRY

  • SuperPatch Limited LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07781397 on ClinicalTrials.gov